Selling of pharmaceutical drugs or medical devices through improper discounts or rebates and other pricing schemes be considered fraud:
Government healthcare programs pay for pharmaceuticals and devices at specified rates, often tied to specified cost metrics. Misuse or manipulation of these programs can result in the submission of false claims. Healthcare employers and healthcare whistleblowers are on the lookout for improper discounts and rebates that increase revenue dollars for device manufacturers and pharmaceuticals from Medicare or insurance providers.
